AEterna Zentaris Inc. Banner Image

AEterna Zentaris Inc. has reached its limit for free report views

Work for AEterna Zentaris Inc.? Upgrade Your Profile and unlock all your annual reports.

AEterna Zentaris Inc.

  • Ticker AEZS
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
AEterna Zentaris Inc. Logo Image
  • 11-50 Employees
  • Based in Charleston, South Carolina
Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company’s lead product, Macrilen™ (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macrilen™ is currently marketed in the United States through aMore license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada.
4.8 / 5.0 (79)

AEterna Zentaris Inc. reports have an aggregate usefulness score of 4.8 based on 79 reviews.

AEterna Zentaris Inc.

Most Recent Annual Report

AEterna Zentaris Inc.
MOST RECENT 2022 Annual Report

Report Locked. AEterna Zentaris Inc. has reached its limit for free report views.

Older/Archived Annual Reports

AEterna Zentaris Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!